Watch Joe’s IXperience.
This information is based on Joe's experience. Different patients may have different results. Talk to your doctor about whether IXINITY may be right for you.
9 Reasons why IXINITY was right for Joe
The efficacy analysis of IXINITY in perioperative management included 19 major surgeries. IXINITY was rated as adequate or better in controlling hemostasis post-surgery as assessed by the surgeon.1
In a clinical trial, 71% of bleeding episodes were resolved with 1 infusion and 13% were resolved with 2 infusions.1 Individual response may vary.
The average terminal half-life of IXINITY is 24 hours.1 Individual response may vary.
Consult a healthcare professional before beginning new activities.
This information is based on Joe’s experience. Different patients may have different results. Talk to your doctor about whether IXINITY may be right for you.
Selected Important Safety Information
Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY. The most common side effect that was reported with IXINITY during clinical trials was headache. These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.
Reference: 1. IXINITY [coagulation factor IX (recombinant)] prescribing information. Seattle, WA: Aptevo BioTherapeutics LLC; December 2018.